These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 24148561)

  • 1. L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders.
    Ribas GS; Vargas CR; Wajner M
    Gene; 2014 Jan; 533(2):469-76. PubMed ID: 24148561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological alterations and induction of oxidative stress in glial cells caused by the branched-chain alpha-keto acids accumulating in maple syrup urine disease.
    Funchal C; Latini A; Jacques-Silva MC; Dos Santos AQ; Buzin L; Gottfried C; Wajner M; Pessoa-Pureur R
    Neurochem Int; 2006 Dec; 49(7):640-50. PubMed ID: 16822590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-carnitine Prevents Oxidative Stress in the Brains of Rats Subjected to a Chemically Induced Chronic Model of MSUD.
    Mescka CP; Rosa AP; Schirmbeck G; da Rosa TH; Catarino F; de Souza LO; Guerreiro G; Sitta A; Vargas CR; Dutra-Filho CS
    Mol Neurobiol; 2016 Nov; 53(9):6007-6017. PubMed ID: 26526843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Carnitine supplementation decreases DNA damage in treated MSUD patients.
    Mescka CP; Guerreiro G; Hammerschmidt T; Faverzani J; de Moura Coelho D; Mandredini V; Wayhs CA; Wajner M; Dutra-Filho CS; Vargas CR
    Mutat Res; 2015 May; 775():43-7. PubMed ID: 25867118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and cellular modifiers of oxidative stress: what can we learn from fatty acid oxidation defects?
    Olsen RK; Cornelius N; Gregersen N
    Mol Genet Metab; 2013; 110 Suppl():S31-9. PubMed ID: 24206932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insults: metabolic inhibitors, MPTP, and methamphetamine.
    Virmani A; Gaetani F; Binienda Z
    Ann N Y Acad Sci; 2005 Aug; 1053():183-91. PubMed ID: 16179522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of DNA damage by L-carnitine induced by metabolites accumulated in maple syrup urine disease in human peripheral leukocytes in vitro.
    Mescka CP; Wayhs CA; Guerreiro G; Manfredini V; Dutra-Filho CS; Vargas CR
    Gene; 2014 Sep; 548(2):294-8. PubMed ID: 25046137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo neuroprotective effect of L-carnitine against oxidative stress in maple syrup urine disease.
    Mescka C; Moraes T; Rosa A; Mazzola P; Piccoli B; Jacques C; Dalazen G; Coelho J; Cortes M; Terra M; Regla Vargas C; Dutra-Filho CS
    Metab Brain Dis; 2011 Mar; 26(1):21-8. PubMed ID: 21380499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New genetic defects in mitochondrial fatty acid oxidation and carnitine deficiency.
    Stanley CA
    Adv Pediatr; 1987; 34():59-88. PubMed ID: 3318304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary biomarkers of oxidative damage in Maple syrup urine disease: the L-carnitine role.
    Guerreiro G; Mescka CP; Sitta A; Donida B; Marchetti D; Hammerschmidt T; Faverzani J; Coelho Dde M; Wajner M; Dutra-Filho CS; Vargas CR
    Int J Dev Neurosci; 2015 May; 42():10-4. PubMed ID: 25680940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R; Merli E; Cicchitelli G; Mele D; Fucili A; Ceconi C
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-keto acids accumulating in maple syrup urine disease stimulate lipid peroxidation and reduce antioxidant defences in cerebral cortex from young rats.
    Bridi R; Braun CA; Zorzi GK; Wannmacher CM; Wajner M; Lissi EG; Dutra-Filho CS
    Metab Brain Dis; 2005 Jun; 20(2):155-67. PubMed ID: 15938133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of carnitine esters in brain neuropathology.
    Virmani A; Binienda Z
    Mol Aspects Med; 2004; 25(5-6):533-49. PubMed ID: 15363640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of inflammatory profile in MSUD patients: benefit of L-carnitine supplementation.
    Mescka CP; Guerreiro G; Donida B; Marchetti D; Wayhs CA; Ribas GS; Coitinho AS; Wajner M; Dutra-Filho CS; Vargas CR
    Metab Brain Dis; 2015 Oct; 30(5):1167-74. PubMed ID: 26002427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of time-dependent oxidative stress and related transcriptional effects of perfluorododecanoic acid in zebrafish liver.
    Liu Y; Wang J; Wei Y; Zhang H; Xu M; Dai J
    Aquat Toxicol; 2008 Sep; 89(4):242-50. PubMed ID: 18760846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats.
    Gómez-Amores L; Mate A; Revilla E; Santa-María C; Vázquez CM
    Life Sci; 2006 Mar; 78(17):1945-52. PubMed ID: 16263137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative damage in glutaric aciduria type I patients and the protective effects of l-carnitine treatment.
    Guerreiro G; Faverzani J; Jacques CED; Marchetti DP; Sitta A; de Moura Coelho D; Kayser A; Kok F; Athayde L; Manfredini V; Wajner M; Vargas CR
    J Cell Biochem; 2018 Dec; 119(12):10021-10032. PubMed ID: 30129250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-chain fatty acids accumulating in MCAD deficiency elicit lipid and protein oxidative damage and decrease non-enzymatic antioxidant defenses in rat brain.
    Schuck PF; Ferreira GC; Moura AP; Busanello EN; Tonin AM; Dutra-Filho CS; Wajner M
    Neurochem Int; 2009 Jul; 54(8):519-25. PubMed ID: 19428797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.